Global Financial Private Client, LLC Moderna, Inc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q4 2024
A detailed history of Global Financial Private Client, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 78 shares of MRNA stock, worth $3,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 223
65.02%
Holding current value
$3,074
Previous $14.9 Million
78.24%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
913Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.53 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...